Author:
Ratterman Megan,Hallmeyer Sigrun,Richards Jon
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Reference31 articles.
1. Bulliard J. Site-specific risk of cutaneous malignant melanoma and pattern of sun exposure in New Zealand. Int J Cancer. 2000;85:627–32.
2. Elwood JM, Gallagher RP. Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure. J Cancer. 1998;78:276–80.
3. Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol. 2006;24:4340–6.
4. Hodis E, Watson I, Kryukov G, Arold S, Imielinski M, Theurillat J, et al. A landscape of driver mutations in melanoma. Cell. 2012;150:251–63.
5. Ding L, Kim M, Kanchi KL, Dees ND, Lu C, Griffith M, David F, Sung H, Miller C, Goetz B, Wendl MC, Griffith O, Cornelius LA, Linette GP, McMichael J, Sondak V, Fields R, Ley T, Mule J, Wilson R, Weber J. Clonal architectures and driver mutations in metastatic melanomas. PLoS One. 2014;9(11):e111153. doi: 10.1371/journal.pone.0111153 .
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献